Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.
about
Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable DiseasesDetecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry.Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.Assessment of glucagon-like peptide-1 analogue and renin inhibitor on the binding and regulation of GLP-1 receptor in type 1 diabetic rat hearts.
P2860
Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aliskiren--an orally active re ...... the treatment of hypertension.
@en
Aliskiren--an orally active re ...... the treatment of hypertension.
@nl
type
label
Aliskiren--an orally active re ...... the treatment of hypertension.
@en
Aliskiren--an orally active re ...... the treatment of hypertension.
@nl
prefLabel
Aliskiren--an orally active re ...... the treatment of hypertension.
@en
Aliskiren--an orally active re ...... the treatment of hypertension.
@nl
P2860
P921
P1476
Aliskiren--an orally active re ...... the treatment of hypertension.
@en
P2093
Kristina Allikmets
P2860
P304
P407
P577
2007-01-01T00:00:00Z